Literature DB >> 9405164

Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.

D E Dostal1, R A Hunt, C E Kule, G J Bhat, V Karoor, C D McWhinney, K M Baker.   

Abstract

Angiotensin II (Ang II), the effector peptide of the renin-angiotensin system (RAS), regulates volume and electrolyte homeostasis and is involved in cardiac and vascular cellular growth in humans and other species. This system, which has been conserved throughout evolution, plays an important role in cardiac and vascular pathology associated with hypertension, coronary heart disease, myocarditis and congestive heart failure. The traditional RAS is viewed as a system in which circulating Ang II is delivered to target organs and cells. However, in the past decade, a local RAS has been described in cardiac cells, providing evidence for autocrine and paracrine pathways by which biological actions of Ang II could be mediated. The critical actions of Ang II are mediated primarily through the AT1, G-protein (guanylyl nucleotide binding protein) coupled receptor. In addition to coupling to conventional G-protein signal transduction pathways, the AT1 receptor was recently shown to increase the tyrosine phosphorylation of several intracellular substrates, including the STAT (Signal Transducers and Activators of Transcription) family of novel transcription factors, in rat cardiac fibroblasts, myocytes and vascular smooth muscle cells, and AT1 receptor transfected CHO cells. It has been shown that Ang II stimulates the tyrosine phosphorylation and nuclear translocation of Stat1 (Stat 91) and Stat3 (Stat 92). Angiotensin II acting directly through the AT1 receptor, induces the formation of a complex of STAT proteins termed SIF (sis-inducing factor) which binds the DNA sequence, SIE (sis-inducing element) present in the promotor element of many genes. This provides evidence for a direct role of Ang II in mediating inflammatory and remodeling responses through the JAK-STAT pathway. Thus, it is likely that the JAK-STAT pathway has an important role in Ang II-mediated effects on gene transcription, cardiac and vascular cellular growth/development, and inflammatory responses. Copyright 1997 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405164     DOI: 10.1006/jmcc.1997.0524

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  27 in total

Review 1.  Unravelling the Lesser Known Facets of Angiotensin II Type 1 Receptor.

Authors:  Mayank Chaudhary; Shashi Chaudhary
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

2.  Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae.

Authors:  H Ju; V J Venema; H Liang; M B Harris; R Zou; R C Venema
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

3.  Phylogenetic Diversity of Sponge-Associated Fungi from the Caribbean and the Pacific of Panama and Their In Vitro Effect on Angiotensin and Endothelin Receptors.

Authors:  Jessica Bolaños; Luis Fernando De León; Edgardo Ochoa; José Darias; Huzefa A Raja; Carol A Shearer; Andrew N Miller; Patrick Vanderheyden; Andrea Porras-Alfaro; Catherina Caballero-George
Journal:  Mar Biotechnol (NY)       Date:  2015-05-31       Impact factor: 3.619

4.  Role of cardiac renin-angiotensin system in sarcoplasmic reticulum function and gene expression in the ischemic-reperfused heart.

Authors:  S Takeo; Y Nasa; K Tanonaka; F Yamaguchi; K Yabe; H Hayashi; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

5.  Transient receptor potential (TRP) protein 7 acts as a G protein-activated Ca2+ channel mediating angiotensin II-induced myocardial apoptosis.

Authors:  Shinji Satoh; Haruki Tanaka; Yasuko Ueda; Jun-Ichi Oyama; Masahiro Sugano; Hideki Sumimoto; Yasuo Mori; Naoki Makino
Journal:  Mol Cell Biochem       Date:  2006-07-13       Impact factor: 3.396

6.  Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2.

Authors:  C Pellieux; A Foletti; G Peduto; J F Aubert; J Nussberger; F Beermann; H R Brunner; T Pedrazzini
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

7.  Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species.

Authors:  Annet Kirabo; Patrick N Kearns; Yagna P Jarajapu; Jennifer M Sasser; Suk Paul Oh; Maria B Grant; Hideko Kasahara; Arturo J Cardounel; Chris Baylis; Kay-Uwe Wagner; Peter P Sayeski
Journal:  Cardiovasc Res       Date:  2011-02-24       Impact factor: 10.787

8.  Cirrhotic cardiomyopathy.

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2008-11-11       Impact factor: 6.047

9.  Losartan affects glomerular AKT and mTOR phosphorylation in an experimental model of type 1 diabetic nephropathy.

Authors:  Vasiliki Mavroeidi; Ioannis Petrakis; Kostas Stylianou; Theodora Katsarou; Konstantinos Giannakakis; Kostas Perakis; Eleftheria Vardaki; Spyridon Stratigis; Emmanuel Ganotakis; Stathis Papavasiliou; Eugenios Daphnis
Journal:  J Histochem Cytochem       Date:  2013-03-01       Impact factor: 2.479

10.  Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes.

Authors:  Felix M Heidrich; Kun Zhang; Manuel Estrada; Yan Huang; Frank J Giordano; Barbara E Ehrlich
Journal:  Circ Res       Date:  2008-04-17       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.